Navigation Links
CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
Date:11/21/2008

ave psoriasis(2), a distressing chronic inflammatory disease. Approximately 80 per cent of these patients have plaque psoriasis, which is characterised by red, scaly patches.(3) Psoriasis can be extremely distressing, and may have a significant impact on patients' quality of life. It is a condition which is frequently physically and psychologically disabling.(4)

Currently, treatments for children and adolescents with psoriasis are mainly limited to topical medications that are applied directly to the skin. Whilst these treatments may be effective at reducing the visible skin lesions and associated symptoms, they are generally used for mild and moderate forms of paediatric psoriasis.

Enbrel is an innovative drug that works by reducing the chronic inflammation that leads to plaque psoriasis.

To access further media information relating to this press release, additional information on Enbrel and future media announcements, please register on the media centre athttp://www.wyeth.eu. If you subscribe to receive our emails you will get updates as soon as new content added to the site. Please note you will be able to unsubscribe at any time and we will not pass your details to any third party.

Notes To Editors

"The 211 study: Enbrel(R) in children and adolescents(5)

The 48 week study involved 211 patients with moderate-to-severe psoriasis aged four to 17 years. During the first 12 weeks of the trial, patients received once weekly injections of either placebo or 0.8 mg of Enbrel per kilogram of body weight up to a maximum of 50 mg. For the next 24 consecutive weeks, all patients went on to receive Enbrel. The 138 patients still participating at week 36 were then re-randomised to receive either placebo or Enbrel in order to investigate whether stopping treatment would lead to any rebound.

At week 12, almost tw
'/>"/>

SOURCE Wyeth Pharmaceuticals Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Task Force Recommends Screening for Hearing Loss in All Newborns
2. FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
3. FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
4. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
5. CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes
6. Tibotec Data Presented at ICAAC and HIV9 Follow Key Regulatory Approvals for Anti-HIV Compounds
7. Berlin Hearts EXCOR(R) Pediatric Receives Unconditional Investigational Device Exemption (IDE) Approval
8. Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval
9. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
10. Sunshine Heart Announces IDE Approval To Begin C-Pulse U.S. Clinical Feasibility Trial
11. Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015 /PRNewswire/ ... MXIM ) makes it easy to ... to monitor or control unsanitary reuse ... gamma-radiation-resistant, nonvolatile (NV) 1-Wire® memory. ... http://www.maximintegrated.com/en/products/digital/memory-products/DS28E80.html , Maxim,s ...
(Date:5/27/2015)...  Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce ... Financial Officer, will present at the Jefferies 2015 Global Healthcare ... New York City . The ... the Cambrex website at www.cambrex.com in the Investors ... available for 90 days after the live event concludes.  ...
(Date:5/27/2015)... 2015  CytRx Corporation (NASDAQ: CYTR ), a ... announced an upcoming poster presentation regarding its lead drug ... Oncology (ASCO) Annual Meeting, which is being held May ... . "I am impressed by the ... who have undergone treatment with aldoxorubicin across several cancer ...
Breaking Medicine Technology:Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 2Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 3CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 2CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 3CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 4CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 5
... MIAMI , July 12 Fuisz Pharma today announced that ... Dye" (invented by Dr. Thomas Gruber )).  This patent covers the ... method to prevent the improper use of opiate derived drugs by visually ... , Fuisz ...
... Surgical Technology, Inc. recently expanded its Biologics Product Specialist program to provide ... that address bone and soft tissue repair. , ... Mr. Shane Ray , General Manager for ... innovative biologic products and to compete with well established biologic providers in ...
Cached Medicine Technology:Fuisz Pharma Announces Acquisition of Key Anti Opiate Abuse Patent to Complement its Anti Opiate Abuse Platform 2Pioneer® Surgical Expands Product Specialists to Support Growing Biologics Business 2
(Date:5/27/2015)... (PRWEB) May 27, 2015 Coco Libre announced ... be able to reach for Organic Coconut Water to quench ... will be available at VIP areas, artist greenrooms, corporate skyboxes ... available at area hotels and on festival shuttle buses. ... this year,” said Noa Elan, Director of Strategic Partnerships for ...
(Date:5/27/2015)... Cincinnati Veterans Affairs Women’s Health Clinic in ... Foundation is proud to host the first annual Women Veterans ... 11 at the Freedom Center from 6 p.m. to 10 ... emcee. , This event honors and celebrates women tri-state ... The banquet is free to the first 150 women Veterans ...
(Date:5/27/2015)... Arizona (PRWEB) May 27, 2015 Genius ... of their advanced programmatic marketing technology, they have boosted ... advertising support on a regional level for seven Utah-based ... marketing was through television and radio media. In 2014 ... with the help of Genius Monkey , shifted ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 With InnerVoice ... communication environment where the message is not only heard but ... drawing, or virtually any motivating image. This award-winning and affordable ... offer. , Now, using InnerVoice Sender app ... be sent to a learner remotely for no additional cost. ...
(Date:5/27/2015)... With a prevalently high rate of ... the "ACA - Controlling the Chaos" webinar revealed that, ... in the process of researching ACA solution options ... for the reporting mandates. , According to a sample ... who are currently vetting ACA reporting solutions are on ...
Breaking Medicine News(10 mins):Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2Health News:Cincinnati VA Women’s Health Clinic Celebrates Women Veterans at Awards Banquet 2Health News:Genius Monkey Boosts Utah Honda Dealers Website Traffic 142% 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 3Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 4Health News:Employers are On Track for ACA Reporting According to Businessolver Poll 2
... but also helps strengthen them, according to research//. ... interference (competing information). Forty-eight people between the ages of ... had normal, healthy sleep routines and were not taking ... wake group without interference, a wake group with interference, ...
... says targeting smaller lesions does little to significantly reduce ... results in extremely high// financial costs and a large ... the low malignancy rate among so-called diminutive polyps gives ... greater the best estimated value per life year gained ...
... sufferers are usually treated with the drug called levodopa ... prolonged use of the drug, many patients may experience ... ,Parkinson's disease is a slow process of ... levels fall, the symptoms of Parkinson’s shows up as ...
... the menopausal transition experience hot flashes: unpredictable, sometimes disruptive, ... and face. Although generations of physicians have prescribed hormones ... on the underlying causes of hot flashes. ,Three ... alcohol consumption in contributing to – or lessening – ...
... Cancer Center have zeroed in on a crucial gene, ... breast cancer and resistance// to long-term estrogen deprivation. The ... of breast cancer reappearance, and would enable a good ... ,The research targeted breast cancer cells which ...
... two genes could determine the vulnerability of the elderly to ... ,Age-related macular degeneration (AMD) is a disease associated ... is needed for seeing objects clearly and for common daily ... affects the macula, the part of the eye that allows ...
Cached Medicine News:Health News:Sleep Makes Your Memory Strong 2Health News:Virtual Colonoscopy is Most-effective for Screening Colon Cancer 2Health News:Hot Flashes: Studies Explore the Various Possibilities Involved 2Health News:Hot Flashes: Studies Explore the Various Possibilities Involved 3Health News:Genes Responsible for a Blinding Condition Identified 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: